Doubts and Suggestions 
Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study
| dc.contributor.author | Brand, Randall E. | |
| dc.contributor.author | Persson, Jan | |
| dc.contributor.author | Bratlie, Svein Olav | |
| dc.contributor.author | Chung, Daniel C. | |
| dc.contributor.author | Katona, Bryson W. | |
| dc.contributor.author | Carrato, Alfredo | |
| dc.contributor.author | Castillo, María Encarnación | |
| dc.contributor.author | Earl, Julie | |
| dc.contributor.author | Kokkola, Arto | |
| dc.contributor.author | Lucas, Aimee L. | |
| dc.contributor.author | Moser, A. James | |
| dc.contributor.author | DeCicco, Corinne | |
| dc.contributor.author | Dexlin Mellby, Linda | |
| dc.contributor.author | King, Thomas C | |
| dc.date.accessioned | 2024-02-07T14:48:56Z | |
| dc.date.available | 2024-02-07T14:48:56Z | |
| dc.date.created | 2022-02 | |
| dc.date.issued | 2022-02 | |
| dc.description.abstract | The IMMray PanCan-d test combines an 8-plex biomarker signature with CA19-9 in a proprietary algorithm to detect pancreatic ductal adenocarcinoma (PDAC) in serum samples. This study aimed to validate the clinical performance of the IMMray PanCan-d test and to better understand test performance in Lewis-null (le/le) individuals who cannot express CA19-9. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.identifier.location | N/A | es_ES |
| dc.identifier.uri | https://hdl.handle.net/20.500.12080/39553 | |
| dc.language | eng | es_ES |
| dc.rights | CC-BY | es_ES |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.es | es_ES |
| dc.title | Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |